Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia

NCT03346668 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Minnesota